Cargando…
Personalized medicine in severe influenza
Existing therapies against infectious diseases may only be effective in limited subpopulations during specific phases of diseases, incorporating theranostics, and there is a clear need to individualize different therapeutic approaches depending on the host. Influenza A virus infection evolves into a...
Autores principales: | Valenzuela-Sánchez, F., Valenzuela-Méndez, B., Rodríguez-Gutiérrez, J. F., Rello, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101819/ https://www.ncbi.nlm.nih.gov/pubmed/26936615 http://dx.doi.org/10.1007/s10096-016-2611-2 |
Ejemplares similares
-
Initial levels of mr-proadrenomedullin: a predictor of severity in patients with influenza a virus pneumonia
por: Valenzuela Sanchez, F, et al.
Publicado: (2015) -
Plasma Levels of Mid-Regional Proadrenomedullin Accurately Identify H1N1pdm09 Influenza Virus Patients with Risk of Intensive Care Admission and Mortality in the Emergency Department
por: Valenzuela-Méndez, Blanca, et al.
Publicado: (2022) -
Diagnostic and prognostic usefulness of mid-regional pro-adrenomedullin levels in patients with severe sepsis
por: Valenzuela Sanchez, F, et al.
Publicado: (2015) -
Sepsis: A Review of Advances in Management
por: Rello, Jordi, et al.
Publicado: (2017) -
Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review
por: Önal, Uğur, et al.
Publicado: (2018)